Consumers are increasingly drawn to delivery formats that feel clinical — peptides, drips, injectables — because they promise faster, more visible results than a capsule or gummy. That expectation is spilling into the broader supplement category, and it's putting pressure on brand owners to offer something that feels more potent without stepping into drug-regulation territory.
This is where format choice matters more than ever. Transdermal patches, functional beverages, and fortified foods can deliver actives in ways that feel modern and fast-acting while staying squarely within supplement and food regulatory frameworks in the US, Mexico, and across LATAM. The brands that win here won't be the ones chasing injectable claims they can't legally back up — they'll be the ones working with manufacturers who can formulate for absorption, bioavailability, and consumer experience within compliant categories.
For buyers evaluating co-manufacturers, this is a good moment to ask pointed questions about formulation science, regulatory awareness across multiple markets, and whether a partner can help translate a trendy delivery concept into something that's actually manufacturable and sellable.